Patents by Inventor Scott Tilden

Scott Tilden has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Virtual slit cycloidal mass spectrometer
    Patent number: 12131894
    Abstract: A virtual slit cycloidal mass spectrometer and spectrometry methods are disclosed. The spectrometer size-selects particles, which in turn serve as a “virtual slit” for a cycloidal mass analyzer. This virtual slit provides unprecedented resolution in a system that takes up a much smaller physical footprint than was previously achievable. This spectrometer may facilitate field sampling of isotopes, such as uranium isotopes.
    Type: Grant
    Filed: May 27, 2022
    Date of Patent: October 29, 2024
    Assignees: DUKE UNIVERSITY, ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA
    Inventors: M. Bonner Denton, Jason Amsden, Rafael Bento Serpa, Charles Parker, Elettra Piacentino, Rob Kingston, Scott Tilden, Roger Sperline, Justin Keogh
  • VIRTUAL SLIT CYCLOIDAL MASS SPECTROMETER
    Publication number: 20240290604
    Abstract: A virtual slit cycloidal mass spectrometer and spectrometry methods are disclosed. The spectrometer size-selects particles, which in turn serve as a “virtual slit” for a cycloidal mass analyzer. This virtual slit provides unprecedented resolution in a system that takes up a much smaller physical footprint than was previously achievable. This spectrometer may facilitate field sampling of isotopes, such as uranium isotopes.
    Type: Application
    Filed: May 27, 2022
    Publication date: August 29, 2024
    Inventors: M. Bonner Denton, Jason Amsden, Rafael Bento Serpa, Charles Parker, Elettra Piacentino, Rob Kingston, Scott Tilden, Roger Sperline, Justin Keogh
  • METHOD FOR REDUCING OFF-TARGET UPTAKE OR ACCUMULATION OF AGENTS
    Publication number: 20230190653
    Abstract: Described herein are compositions and methods for reducing off-target deposition of therapeutic and/or imaging agents in a subject with cancer comprising administering to the subject a predose of an interferon composition and/or a nucleic acid and a nanoparticle mimic, e.g., a lipoplex composition or a virus-like particle, such that epithelial tightening occurs in nontumor tissue of the subject thereby reducing uptake or accumulation of the therapeutic and/or imaging agent in off-target, nontumor tissue compared to tumor tissue.
    Type: Application
    Filed: December 19, 2022
    Publication date: June 22, 2023
    Inventors: Thomas Anchordoquy, Jamie Betker, Scott Tilden